Career Enhancement and Related Activities A major strategic initiative for UPMC Hillman Cancer Center (HCC) is to develop a well-trained, diverse biomedical workforce through research education, training, and career-development activities that promote the understanding of the biology and treatment of cancer. To this end, the HCC Committee for Excellence in Cancer Education and Training (CECET) meets 4 times a year to review the breadth, depth, accessibility, and effectiveness of available education and training opportunities and to develop new programs as needed. CECET overseas an HCC investment of ~$1.4M/year in education and training. Our work is organized through three main specific aims designed to provide career enhancement opportunities across the biomedical training pipeline.
The first aim i s to educate and inspire high school and undergraduate students about careers in cancer research with a focus on serving underrepresented populations. The Hillman Academy has provided an 8-week summer internship introducing careers in cancer research to 433 high school students, including 175 (40%) underrepresented minority and disadvantaged (URM/DA) in our catchment area (CA). The Academy is supported by the Doris Duke Charitable Foundation, CURE and the Jack Kent Foundation, and the award of a new R25CA236620 allows an immediate 70% increase in the number of URM/DA students. This new R25CA236620 also provides support to improve the science literacy of our surrounding community by developing 1-day workshops that include hands-on activities, tours of facilities, and career seminars on cancer research.
Our second aim i s to encourage medical and doctoral students as well as clinical and postdoctoral fellows to pursue careers in cancer research. We have used HCC philanthropy to recruit the first class of Hillman Medical Student and Postdoctoral Fellows for Innovative Cancer Research. We have increased the number of NCI T32 training grants from 4 to 6 to support the cancer research focus of all CCSG programs. Our commitment to graduate student researcher (GSR) education is evidenced by our support of more GSRs than any other Pitt SOM Institute or Department. At the request of the newly formed HCC postdoctoral association, we have established a new grant writing class that tailors K99 R00 applications to the NCI. This initiative builds on previous F30, F31, F99 K00 and K00 R01 successes. We will extend our Hillman Fellows for Innovative Cancer Research program into a new ?Bridge to Faculty? positions that will guarantee faculty positions when key metrics are attained.
Our third aim i s to enhance the professional growth of faculty through an extensive, multi-faceted faculty mentorship program that eliminates barriers to innovative cancer research and strengthens R01 applications to the NCI. We will also increase efforts across our network to ensure equal access of our health care providers to exceptional cancer education and training programs, such as Accountability for Cancer Care through Undoing Racism and Equity and AP-POWER (R25CA148050).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA047904-32
Application #
10024336
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-09-10
Project End
2025-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
32
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15260
Wang, Yue; Wang, Zehua; Xu, Jieni et al. (2018) Systematic identification of non-coding pharmacogenomic landscape in cancer. Nat Commun 9:3192
Lee, Young-Sun; Lee, Dae-Hee; Choudry, Haroon A et al. (2018) Ferroptosis-Induced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis. Mol Cancer Res 16:1073-1076
Tong, Jingshan; Zheng, Xingnan; Tan, Xiao et al. (2018) Mcl-1 Phosphorylation without Degradation Mediates Sensitivity to HDAC Inhibitors by Liberating BH3-Only Proteins. Cancer Res 78:4704-4715
Menk, Ashley V; Scharping, Nicole E; Rivadeneira, Dayana B et al. (2018) 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses. J Exp Med 215:1091-1100
Caves, Elizabeth A; Cook, Sarah A; Lee, Nara et al. (2018) Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells. mSphere 3:
Saydmohammed, Manush; Vollmer, Laura L; Onuoha, Ezenwa O et al. (2018) A High-Content Screen Reveals New Small-Molecule Enhancers of Ras/Mapk Signaling as Probes for Zebrafish Heart Development. Molecules 23:
Gough, Albert; Shun, Tong Ying; Taylor, D Lansing et al. (2018) Integrating Analysis of Cellular Heterogeneity in High-Content Dose-Response Studies. Methods Mol Biol 1745:25-46
Fletcher, Rochelle; Wang, Yi-Jun; Schoen, Robert E et al. (2018) Colorectal cancer prevention: Immune modulation taking the stage. Biochim Biophys Acta Rev Cancer 1869:138-148
Li, Xiang; George, Subin M; Vernetti, Lawrence et al. (2018) A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX. Lab Chip 18:2614-2631
Singh, Renu; Mehrotra, Shailly; Gopalakrishnan, Mathangi et al. (2018) Population pharmacokinetics and exposure-response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias. Cancer Chemother Pharmacol :

Showing the most recent 10 out of 1187 publications